Cinclus Pharma (CINPHA) — Net Asset Momentum
Cinclus Pharma (CINPHA) recorded a net asset momentum of -33.5% as of December 2025, with net assets of Skr369.39 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Cinclus Pharma book value and equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Cinclus Pharma Net Asset Momentum (2022–2025)
This chart tracks Cinclus Pharma's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is -33.5%, with net assets of Skr369.39 Million SEK as of December 2025. For live market cap and overall valuation, see Cinclus Pharma (CINPHA) total market value.
Annual Net Asset History for Cinclus Pharma (2022–2025)
The table below shows the complete annual net asset history for Cinclus Pharma from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check CINPHA goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Skr369.39 Million | Skr546.56 Million | Skr177.16 Million | ▼ -33.5% |
| 2024 | Skr555.33 Million | Skr601.01 Million | Skr45.68 Million | ▲ +823.1% |
| 2023 | Skr-76.80 Million | Skr94.41 Million | Skr171.21 Million | ▼ -160.5% |
| 2022 | Skr126.87 Million | Skr185.77 Million | Skr58.90 Million | — |